PTCT Long Put Strategy
PTCT (PTC Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older.
PTCT (PTC Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.00B, a beta of 0.55 versus the broader market, a 52-week range of 43.175-87.5, average daily share volume of 1.5M, a public-listing history dating back to 2013, approximately 939 full-time employees. These structural characteristics shape how PTCT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.55 indicates PTCT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a long put on PTCT?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current PTCT snapshot
As of June 30, 2026, spot at $81.76, ATM IV 52.00%, IV rank 23.19%, expected move 14.91%. The long put on PTCT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 199-day expiry.
Why this long put structure on PTCT specifically: PTCT IV at 52.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a PTCT long put, with a market-implied 1-standard-deviation move of approximately 14.91% (roughly $12.19 on the underlying). The 199-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PTCT expiries trade a higher absolute premium for lower per-day decay. Position sizing on PTCT should anchor to the underlying notional of $81.76 per share and to the trader's directional view on PTCT stock.
PTCT long put setup
The PTCT long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PTCT near $81.76, the first option leg uses a $80.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PTCT chain at a 199-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PTCT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $80.00 | $11.30 |
PTCT long put risk and reward
- Net Premium / Debit
- -$1,130.00
- Max Profit (per contract)
- $6,869.00
- Max Loss (per contract)
- -$1,130.00
- Breakeven(s)
- $68.70
- Risk / Reward Ratio
- 6.079
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
PTCT long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on PTCT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$6,869.00 |
| $18.09 | -77.9% | +$5,061.35 |
| $36.16 | -55.8% | +$3,253.70 |
| $54.24 | -33.7% | +$1,446.06 |
| $72.32 | -11.6% | -$361.59 |
| $90.39 | +10.6% | -$1,130.00 |
| $108.47 | +32.7% | -$1,130.00 |
| $126.55 | +54.8% | -$1,130.00 |
| $144.62 | +76.9% | -$1,130.00 |
| $162.70 | +99.0% | -$1,130.00 |
When traders use long put on PTCT
Long puts on PTCT hedge an existing long PTCT stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying PTCT exposure being hedged.
PTCT thesis for this long put
The market-implied 1-standard-deviation range for PTCT extends from approximately $69.57 on the downside to $93.95 on the upside. A PTCT long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long PTCT position with one put per 100 shares held. Current PTCT IV rank near 23.19% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PTCT at 52.00%. As a Healthcare name, PTCT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PTCT-specific events.
PTCT long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PTCT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PTCT alongside the broader basket even when PTCT-specific fundamentals are unchanged. Long-premium structures like a long put on PTCT are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current PTCT chain quotes before placing a trade.
Frequently asked questions
- What is a long put on PTCT?
- A long put on PTCT is the long put strategy applied to PTCT (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With PTCT stock trading near $81.76, the strikes shown on this page are snapped to the nearest listed PTCT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PTCT long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the PTCT long put priced from the end-of-day chain at a 30-day expiry (ATM IV 52.00%), the computed maximum profit is $6,869.00 per contract and the computed maximum loss is -$1,130.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PTCT long put?
- The breakeven for the PTCT long put priced on this page is roughly $68.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PTCT market-implied 1-standard-deviation expected move is approximately 14.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on PTCT?
- Long puts on PTCT hedge an existing long PTCT stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying PTCT exposure being hedged.
- How does current PTCT implied volatility affect this long put?
- PTCT ATM IV is at 52.00% with IV rank near 23.19%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.